Immediate Impact
65 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of María E. Sabbatini being referenced
The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| María E. Sabbatini | 131 | 200 | 290 | 26 | 602 | |
| Camilla Cerutti | 79 | 130 | 281 | 19 | 739 | |
| Feng Ye | 69 | 120 | 320 | 30 | 712 | |
| Hekun Liu | 71 | 164 | 347 | 32 | 612 | |
| Claire Rutherford | 94 | 102 | 331 | 20 | 590 | |
| Christine Shugrue | 255 | 144 | 333 | 22 | 700 | |
| Nagadhara Dronadula | 145 | 114 | 354 | 22 | 638 | |
| Joanne M. Wroblewski | 220 | 105 | 277 | 20 | 593 | |
| Alicia Zukas | 106 | 148 | 165 | 21 | 660 | |
| C. Delbart | 174 | 128 | 257 | 23 | 659 | |
| Yanfang Pan | 83 | 217 | 222 | 21 | 597 |
All Works
Login with ORCID to disown or claim papers
Loading papers...